TRLV logo

Trulieve Cannabis Corp. Subordinate (TRLV)

$10.07

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on TRLV

Market cap

$1.94B

EPS

-2.32

P/E ratio

--

Price to sales

1.8

Dividend yield

--

Beta

12.159358

Price on TRLV

Previous close

$10.33

Today's open

$10.39

Day's range

$9.88 - $10.56

52 week range

$7.82 - $12.93

Profile about TRLV

CEO

Kim Rivers

Employees

5000

Headquarters

Tallahassee, FL

Exchange

New York Stock Exchange

Shares outstanding

192813955

Issue type

Common Stock

TRLV industries and sectors

Healthcare

Pharmaceuticals

News on TRLV

Trulieve Announces Preliminary Addition to the Russell 2000® and 3000® Indices

TALLAHASSEE, Fla., Nov. 16, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (NYSE: TRLV) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S., today announced that the company is set to join to the Russell 2000® and 3000® Indices as part of the semi-annual Russell Indexes reconstitution, according to a preliminary list published by FTSE Russell on Friday, November 13, 2026.

news source

PRNewsWire • Nov 16, 2026

news preview

Trulieve to Open Medical Cannabis Dispensary in Tampa, Florida

New Hillsborough County location will host grand opening celebration Friday, November 20 TALLAHASSEE, Fla., Nov. 16, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (NYSE: TRLV) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S., today announced the opening of a new medical cannabis dispensary in Tampa, Florida.

news source

PRNewsWire • Nov 16, 2026

news preview

Trulieve Announces November 2026 Event Participation

TALLAHASSEE, Fla., Nov. 11, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (NYSE: TRLV) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S., today announced planned event participation in November.

news source

PRNewsWire • Nov 11, 2026

news preview

Trulieve Expands Medical Cannabis Access through Riverside Pharmacy in Gainesville, Georgia

New Trulieve-branded kiosk offers qualified patients product access, education, and personalized guidance TALLAHASSEE, Fla., Nov. 10, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (NYSE: TRLV)  ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S., today announced that its medical cannabis products are now available to qualified patients at Riverside Pharmacy in Gainesville, Georgia.

news source

PRNewsWire • Nov 10, 2026

news preview

Marijuana Stocks In 2027: New Risks And Opportunities For Investors

Marijuana stocks continue to attract investors, but trading in the cannabis sector requires understanding risks that extend far beyond quarterly revenue. Regulatory decisions, limited access to exchanges, pricing pressure, and shifting consumer channels can quickly move cannabis stocks—even when a company's underlying operations remain stable.

news preview

Trulieve Cannabis Q3 Earnings Call Highlights

Trulieve Cannabis NYSE: TRLV reported third-quarter revenue of $230 million, up 4% from both a year earlier and the prior quarter on a medical-only basis, as growth in Georgia and Pennsylvania helped the cannabis operator exceed its guidance.

news source

MarketBeat • Nov 8, 2026

news preview

Trulieve Cannabis Corp. (TRLV) Q3 2026 Earnings Call Transcript

Trulieve Cannabis Corp. (TRLV) Q3 2026 Earnings Call Transcript

news source

Seeking Alpha • Nov 5, 2026

news preview

Trulieve Reports Third Quarter 2026 Results

Third quarter revenue of $230 million, with 64% gross margin Cash flow from operations of $183 million and free cash flow of $120 million* in first nine months of 2026 Received final DEA registrations pursuant to final order rescheduling state licensed medical marijuana to Schedule III under the Controlled Substances Act TALLAHASSEE, Fla., Nov. 5, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (NYSE: TRLV) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S., today announced its results for the quarter ended September 30, 2026.

news source

PRNewsWire • Nov 5, 2026

news preview

Trulieve Receives DEA Registrations for State-Licensed Medical Marijuana Operations

TALLAHASSEE, Fla., Nov. 2, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (NYSE: TRLV) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S., today announced that Trulieve has received registrations for medical marijuana dispensaries as part of the initial registrations issued by the U.S. Drug Enforcement Administration (DEA).

news source

PRNewsWire • Nov 2, 2026

news preview

Marijuana Stocks And The Changing U.S. Cannabis Industry

Marijuana stocks are entering a market where financial discipline may matter more than rapid expansion. The cannabis industry continues to generate substantial consumer activity. However, today's investors are increasingly separating companies with improving cash flow and manageable debt from operators still relying heavily on outside financing.

news preview

¹ Disclosures

Get started with M1

Invest in Trulieve Cannabis Corp. Subordinate

Open an M1 investment account to buy and sell Trulieve Cannabis Corp. Subordinate commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in TRLV on M1